CRISPR-Cas9 depletion of ALG3 reduced the staining pattern of all three lectins, indicating that ALG3 is functionally required for protein glycosylation using α-1,3 mannose in breast cancer cells with hyperactive PI3K signaling (Fig. 2, B–D). This evidence concerns the gene ALG3 and breast carcinoma.